Literature DB >> 27826002

3D culture of human pluripotent stem cells in RGD-alginate hydrogel improves retinal tissue development.

Nicola C Hunt1, Dean Hallam2, Ayesha Karimi3, Carla B Mellough4, Jinju Chen5, David H W Steel6, Majlinda Lako7.   

Abstract

No treatments exist to effectively treat many retinal diseases. Retinal pigmented epithelium (RPE) and neural retina can be generated from human embryonic stem cells/induced pluripotent stem cells (hESCs/hiPSCs). The efficacy of current protocols is, however, limited. It was hypothesised that generation of laminated neural retina and/or RPE from hiPSCs/hESCs could be enhanced by three dimensional (3D) culture in hydrogels. hiPSC- and hESC-derived embryoid bodies (EBs) were encapsulated in 0.5% RGD-alginate; 1% RGD-alginate; hyaluronic acid (HA) or HA/gelatin hydrogels and maintained until day 45. Compared with controls (no gel), 0.5% RGD-alginate increased: the percentage of EBs with pigmented RPE foci; the percentage EBs with optic vesicles (OVs) and pigmented RPE simultaneously; the area covered by RPE; frequency of RPE cells (CRALBP+); expression of RPE markers (TYR and RPE65) and the retinal ganglion cell marker, MATH5. Furthermore, 0.5% RGD-alginate hydrogel encapsulation did not adversely affect the expression of other neural retina markers (PROX1, CRX, RCVRN, AP2α or VSX2) as determined by qRT-PCR, or the percentage of VSX2 positive cells as determined by flow cytometry. 1% RGD-alginate increased the percentage of EBs with OVs and/or RPE, but did not significantly influence any other measures of retinal differentiation. HA-based hydrogels had no significant effect on retinal tissue development. The results indicated that derivation of retinal tissue from hESCs/hiPSCs can be enhanced by culture in 0.5% RGD-alginate hydrogel. This RGD-alginate scaffold may be useful for derivation, transport and transplantation of neural retina and RPE, and may also enhance formation of other pigmented, neural or epithelial tissue. STATEMENT OF SIGNIFICANCE: The burden of retinal disease is ever growing with the increasing age of the world-wide population. Transplantation of retinal tissue derived from human pluripotent stem cells (PSCs) is considered a promising treatment. However, derivation of retinal tissue from PSCs using defined media is a lengthy process and often variable between different cell lines. This study indicated that alginate hydrogels enhanced retinal tissue development from PSCs, whereas hyaluronic acid-based hydrogels did not. This is the first study to show that 3D culture with a biomaterial scaffold can improve retinal tissue derivation from PSCs. These findings indicate potential for the clinical application of alginate hydrogels for the derivation and subsequent transplantation retinal tissue. This work may also have implications for the derivation of other pigmented, neural or epithelial tissue. Crown
Copyright © 2016. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Biomaterials; Embryonic stem cells; Induced pluripotent stem cells; Retina; Tissue engineering

Mesh:

Substances:

Year:  2016        PMID: 27826002     DOI: 10.1016/j.actbio.2016.11.016

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  38 in total

Review 1.  Stem cell therapies for retinal diseases: recapitulating development to replace degenerated cells.

Authors:  Cuiping Zhao; Qingjie Wang; Sally Temple
Journal:  Development       Date:  2017-04-15       Impact factor: 6.868

2.  Application of Hanging Drop Culture for Retinal Precursor-Like Cells Differentiation of Human Adipose-Derived Stem Cells Using Small Molecules.

Authors:  Hossein Salehi; Shahnaz Razavi; Ebrahim Esfandiari; Mohammad Kazemi; Shahram Amini; Noushin Amirpour
Journal:  J Mol Neurosci       Date:  2019-07-30       Impact factor: 3.444

3.  Advanced Materials to Enhance Central Nervous System Tissue Modeling and Cell Therapy.

Authors:  Riya J Muckom; Rocío G Sampayo; Hunter J Johnson; David V Schaffer
Journal:  Adv Funct Mater       Date:  2020-08-12       Impact factor: 18.808

Review 4.  Hydrogel-based ocular drug delivery systems: Emerging fabrication strategies, applications, and bench-to-bedside manufacturing considerations.

Authors:  Remy C Cooper; Hu Yang
Journal:  J Control Release       Date:  2019-05-22       Impact factor: 9.776

Review 5.  CRISPR-Cas9 genome engineering: Treating inherited retinal degeneration.

Authors:  Erin R Burnight; Joseph C Giacalone; Jessica A Cooke; Jessica R Thompson; Laura R Bohrer; Kathleen R Chirco; Arlene V Drack; John H Fingert; Kristan S Worthington; Luke A Wiley; Robert F Mullins; Edwin M Stone; Budd A Tucker
Journal:  Prog Retin Eye Res       Date:  2018-03-22       Impact factor: 21.198

Review 6.  Recent progress on engineering microbial alginate lyases towards their versatile role in biotechnological applications.

Authors:  Shivakumar Renuka Dharani; Ramachandran Srinivasan; Reghunathan Sarath; Mohandass Ramya
Journal:  Folia Microbiol (Praha)       Date:  2020-06-04       Impact factor: 2.099

7.  Development of High-Resolution Three-Dimensional-Printed Extracellular Matrix Scaffolds and Their Compatibility with Pluripotent Stem Cells and Early Retinal Cells.

Authors:  Arwin Shrestha; Brittany N Allen; Luke A Wiley; Budd A Tucker; Kristan S Worthington
Journal:  J Ocul Pharmacol Ther       Date:  2019-08-16       Impact factor: 2.671

Review 8.  Biomaterials and Culture Systems for Development of Organoid and Organ-on-a-Chip Models.

Authors:  Katya D'Costa; Milena Kosic; Angus Lam; Azeen Moradipour; Yimu Zhao; Milica Radisic
Journal:  Ann Biomed Eng       Date:  2020-04-13       Impact factor: 3.934

Review 9.  Retinal Tissue Bioengineering, Materials and Methods for the Treatment of Glaucoma.

Authors:  Sanaz Behtaj; Andreas Öchsner; Yuri G Anissimov; Maksym Rybachuk
Journal:  Tissue Eng Regen Med       Date:  2020-05-10       Impact factor: 4.169

Review 10.  Inducing human induced pluripotent stem cell differentiation through embryoid bodies: A practical and stable approach.

Authors:  Ning-Ning Guo; Li-Ping Liu; Yun-Wen Zheng; Yu-Mei Li
Journal:  World J Stem Cells       Date:  2020-01-26       Impact factor: 5.326

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.